We are live on ! Find out more
PCH

Polar Capital Holdings Portfolio holdings

AUM $42.4B
1-Year Est. Return 181.11%
This Fund
S&P 500
This Quarter Est. Return
+6.82%
1 Year Est. Return
+181.11%
3 Year Est. Return
+584.8%
5 Year Est. Return
+777.19%
10 Year Est. Return
AUM
$21B
AUM Growth
+$3.99B
Cap. Flow
-$643M
Cap. Flow %
-3.07%
Top 10 Hldgs %
41.48%
Holding
317
New
46
Increased
82
Reduced
113
Closed
28

Sector Composition

Rank Sector Weight
1 Technology 35.21%
2 Consumer Discretionary 20.16%
3 Financials 14.28%
4 Healthcare 13.93%
5 Communication Services 9.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ANSS
251
DELISTED
Ansys
ANSS
$446K ﹤0.01%
1,400
-23,600
-94% -$7.5M
EHC icon
252
Encompass Health
EHC
$12B
$348K ﹤0.01%
3,600
+270
+8% +$24.3K
XLF icon
253
PUT
State Street Financial Select Sector SPDR ETF
XLF
$54.5B
$295K ﹤0.01%
+6,500
New +$284K
APTV icon
254
Aptiv
APTV
$9.3B
$288K ﹤0.01%
+4,000
New +$279K
HQY icon
255
HealthEquity
HQY
$7.96B
$259K ﹤0.01%
3,160
-1,325
-30% -$102K
TRMB icon
256
Trimble
TRMB
$13.4B
$248K ﹤0.01%
4,000
-1,000
-20% -$55.9K
TEL icon
257
TE Connectivity
TEL
$61.4B
$226K ﹤0.01%
+1,500
New +$225K
NTRA icon
258
Natera
NTRA
$47.4B
$223K ﹤0.01%
1,755
-2,995
-63% -$344K
BABA icon
259
Alibaba
BABA
$272B
$205K ﹤0.01%
+1,928
New +$158K
NTES icon
260
NetEase
NTES
$74B
$202K ﹤0.01%
+2,157
New +$188K
PRVA icon
261
Privia Health
PRVA
$2.61B
$192K ﹤0.01%
10,540
GDRX icon
262
GoodRx Holdings
GDRX
$1.16B
$85.8K ﹤0.01%
+12,360
New +$97K
LFST icon
263
Lifestance Health
LFST
$4.96B
$80.5K ﹤0.01%
+11,500
New +$69.1K
STXS icon
264
Stereotaxis
STXS
$133M
$73K ﹤0.01%
35,800
-22,770
-39% -$45.8K
LAB icon
265
Standard BioTools
LAB
$271M
$68.7K ﹤0.01%
35,585
-21,000
-37% -$41.1K
CERS icon
266
Cerus
CERS
$514M
$23.6K ﹤0.01%
13,540
-13,000
-49% -$27.3K
AKYA
267
DELISTED
Akoya BioSciences
AKYA
-329,756
Closed -$772K
ALB icon
268
Albemarle
ALB
$13.6B
-6,150
Closed -$587K
ALGN icon
269
Align Technology
ALGN
$10.9B
-75,737
Closed -$18.3M
AMAT icon
270
Applied Materials
AMAT
$337B
-593,892
Closed -$140M
APGE
271
DELISTED
Apogee Therapeutics
APGE
-250,000
Closed -$9.84M
BDX icon
272
Becton Dickinson
BDX
$48.4B
-124,013
Closed -$29M
BIIB icon
273
Biogen
BIIB
$32.1B
-225,000
Closed -$52.2M
CABA icon
274
Cabaletta Bio
CABA
$463M
-1,253,500
Closed -$9.38M
CFLT
275
DELISTED
Confluent
CFLT
-4,224,546
Closed -$125M

Similar funds

Polar Capital Holdings's Q3 2024 Portfolio in Review

As of Q3 2024, Polar Capital Holdings held 317 positions worth $21B, up 24% from $17B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Polar Capital Holdings withdrew a net $643M in Q3 2024, closing 28 positions and reducing 113 holdings. Its most notable exit was Applied Materials, an estimated $140M position sold in full.

By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 46% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, Polar Capital Holdings opened a new position in MACOM Technology Solutions worth $122M.

  • Polar Capital Holdings's largest Q3 2024 buy was MACOM Technology Solutions: 1,096,992 shares worth $122M.
  • Polar Capital Holdings added most to Mercado Libre in Q3 2024, an estimated $110M increase.
  • Polar Capital Holdings's biggest Q3 2024 reduction was CrowdStrike, cutting an estimated $214M.
  • Polar Capital Holdings fully exited Applied Materials in Q3 2024, selling an estimated $140M.
  • Polar Capital Holdings's ten largest holdings make up 41% of its $21B portfolio in Q3 2024.
  • Polar Capital Holdings opened 46 new positions and closed 28 in Q3 2024.
  • Polar Capital Holdings's portfolio value rose 24% quarter-over-quarter to $21B.

Based on Polar Capital Holdings's 13F filing for Q3 2024, filed 14 Nov 2024.